FDA Contradicts Benzene Class Actions, Highlighting Risks of Third-Party Lab Testing

Start
In March 2024, Valisure, an independent quality advocate, filed a citizen petition claiming to have detected elevated levels of benzene in benzoyl peroxide acne treatment products. Valisure’s petition included testing results on over-the-counter brands from various retailers as well as prescription acne products….
By: Skadden, Arps, Slate, Meagher & Flom LLP
Previous Story

Stealing user credentials with evilginx

Next Story

Depo-Provera Litigation Update: Women With Meningioma Brain Tumors Eligible for Compensation